Literature DB >> 20948916

RNA regulation in neurologic disease and cancer.

Robert B Darnell1.   

Abstract

The paraneoplastic neurologic diseases (PNDs) are brain degenerations that develop in the setting of clinically inapparent cancers. PNDs arise when common cancers express brain proteins, triggering an anti-tumor immune response and tumor immunity. Research on these brain-cancer proteins has revealed a new world of neuron-specific RNA binding proteins whose functions may be aberrantly used by tumor cells. Efforts to gain insight into their function has led to the development of new methods and strategies to understand RNA protein regulation in living tissues.

Entities:  

Keywords:  CLIP; Nova; Paraneoplastic neurologic degeneration; RNA binding protein; Tumor immunity

Year:  2010        PMID: 20948916      PMCID: PMC2953774          DOI: 10.4143/crt.2010.42.3.125

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  40 in total

Review 1.  Paraneoplastic neurological degenerations: keys to tumour immunity.

Authors:  Matthew L Albert; Robert B Darnell
Journal:  Nat Rev Cancer       Date:  2004-01       Impact factor: 60.716

2.  Nova regulates brain-specific splicing to shape the synapse.

Authors:  Jernej Ule; Aljaz Ule; Joanna Spencer; Alan Williams; Jing-Shan Hu; Melissa Cline; Hui Wang; Tyson Clark; Claire Fraser; Matteo Ruggiu; Barry R Zeeberg; David Kane; John N Weinstein; John Blume; Robert B Darnell
Journal:  Nat Genet       Date:  2005-07-24       Impact factor: 38.330

3.  The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo.

Authors:  R J Buckanovich; R B Darnell
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

Review 4.  Splicing regulation in neurologic disease.

Authors:  Donny D Licatalosi; Robert B Darnell
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

5.  Integrative modeling defines the Nova splicing-regulatory network and its combinatorial controls.

Authors:  Chaolin Zhang; Maria A Frias; Aldo Mele; Matteo Ruggiu; Taesun Eom; Christina B Marney; Huidong Wang; Donny D Licatalosi; John J Fak; Robert B Darnell
Journal:  Science       Date:  2010-06-17       Impact factor: 47.728

Review 6.  RNA processing and its regulation: global insights into biological networks.

Authors:  Donny D Licatalosi; Robert B Darnell
Journal:  Nat Rev Genet       Date:  2010-01       Impact factor: 53.242

7.  The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies.

Authors:  R J Buckanovich; Y Y Yang; R B Darnell
Journal:  J Neurosci       Date:  1996-02-01       Impact factor: 6.167

8.  Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts.

Authors:  Jeremy R Sanford; Xin Wang; Matthew Mort; Natalia Vanduyn; David N Cooper; Sean D Mooney; Howard J Edenberg; Yunlong Liu
Journal:  Genome Res       Date:  2008-12-30       Impact factor: 9.043

9.  A T-cell receptor associated with naturally occurring human tumor immunity.

Authors:  Bianca D Santomasso; Wendy K Roberts; Ashby Thomas; Travis Williams; Nathalie E Blachère; Mark E Dudley; Alan N Houghton; Jerome B Posner; Robert B Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

10.  iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution.

Authors:  Julian König; Kathi Zarnack; Gregor Rot; Tomaz Curk; Melis Kayikci; Blaz Zupan; Daniel J Turner; Nicholas M Luscombe; Jernej Ule
Journal:  Nat Struct Mol Biol       Date:  2010-07-04       Impact factor: 15.369

View more
  16 in total

1.  Probing the RNA-Binding Proteome from Yeast to Man: Major Advances and Challenges.

Authors:  Benedikt M Beckmann; Sander Granneman
Journal:  Methods Mol Biol       Date:  2019

2.  Sequence-Based Prediction of RNA-Binding Residues in Proteins.

Authors:  Rasna R Walia; Yasser El-Manzalawy; Vasant G Honavar; Drena Dobbs
Journal:  Methods Mol Biol       Date:  2017

3.  Development of RNA binding proteins expression signature for prognosis prediction in gastric cancer patients.

Authors:  Liqiang Zhou; You Wu; Lin Xin; Qi Zhou; Shihao Li; Yiwu Yuan; Jinliang Wang; Dengzhong Wu
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

Review 4.  RNA Regulators in Leukemia and Lymphoma.

Authors:  Camila Prieto; Michael G Kharas
Journal:  Cold Spring Harb Perspect Med       Date:  2020-05-01       Impact factor: 6.915

5.  Posttranscriptional regulation of gene expression-adding another layer of complexity to the DNA damage response.

Authors:  Jorge Boucas; Arina Riabinska; Mladen Jokic; Grit S Herter-Sprie; Shuhua Chen; Katja Höpker; H Christian Reinhardt
Journal:  Front Genet       Date:  2012-08-25       Impact factor: 4.599

6.  A versatile assay for RNA-binding proteins in living cells.

Authors:  Claudia Strein; Anne-Marie Alleaume; Ulrich Rothbauer; Matthias W Hentze; Alfredo Castello
Journal:  RNA       Date:  2014-03-24       Impact factor: 4.942

Review 7.  The expanding universe of ribonucleoproteins: of novel RNA-binding proteins and unconventional interactions.

Authors:  Benedikt M Beckmann; Alfredo Castello; Jan Medenbach
Journal:  Pflugers Arch       Date:  2016-05-10       Impact factor: 3.657

8.  Genome-wide approaches to dissect the roles of RNA binding proteins in translational control: implications for neurological diseases.

Authors:  Katannya Kapeli; Gene W Yeo
Journal:  Front Neurosci       Date:  2012-10-02       Impact factor: 4.677

9.  Tumor-promoting function and prognostic significance of the RNA-binding protein T-cell intracellular antigen-1 in esophageal squamous cell carcinoma.

Authors:  Junichi Hamada; Katsutoshi Shoda; Kiyoshi Masuda; Yuji Fujita; Takuya Naruto; Tomohiro Kohmoto; Yuko Miyakami; Miki Watanabe; Yasusei Kudo; Hitoshi Fujiwara; Daisuke Ichikawa; Eigo Otsuji; Issei Imoto
Journal:  Oncotarget       Date:  2016-03-29

10.  NOVA2-mediated RNA regulation is required for axonal pathfinding during development.

Authors:  Yuhki Saito; Soledad Miranda-Rottmann; Matteo Ruggiu; Christopher Y Park; John J Fak; Ru Zhong; Jeremy S Duncan; Brian A Fabella; Harald J Junge; Zhe Chen; Roberto Araya; Bernd Fritzsch; A J Hudspeth; Robert B Darnell
Journal:  Elife       Date:  2016-05-25       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.